182 related articles for article (PubMed ID: 37192292)
1. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.
Girerd N; Levy D; Duarte K; Ferreira JP; Ballantyne C; Collier T; Pizard A; Björkman J; Butler J; Clark A; Cleland JG; Delles C; Diez J; González A; Hazebroek M; Ho J; Huby AC; Hwang SJ; Latini R; Mariottoni B; Mebazaa A; Pellicori P; Sattar N; Sever P; Staessen JA; Verdonschot J; Heymans S; Rossignol P; Zannad F
Circ Heart Fail; 2023 May; 16(5):e009694. PubMed ID: 37192292
[TBL] [Abstract][Full Text] [Related]
2. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.
Ndumele CE; Matsushita K; Sang Y; Lazo M; Agarwal SK; Nambi V; Deswal A; Blumenthal RS; Ballantyne CM; Coresh J; Selvin E
Circulation; 2016 Feb; 133(7):631-8. PubMed ID: 26746175
[TBL] [Abstract][Full Text] [Related]
3. Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study.
Agarwal SK; Chambless LE; Ballantyne CM; Astor B; Bertoni AG; Chang PP; Folsom AR; He M; Hoogeveen RC; Ni H; Quibrera PM; Rosamond WD; Russell SD; Shahar E; Heiss G
Circ Heart Fail; 2012 Jul; 5(4):422-9. PubMed ID: 22589298
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.
Choi EY; Bahrami H; Wu CO; Greenland P; Cushman M; Daniels LB; Almeida AL; Yoneyama K; Opdahl A; Jain A; Criqui MH; Siscovick D; Darwin C; Maisel A; Bluemke DA; Lima JA
Circ Heart Fail; 2012 Nov; 5(6):727-34. PubMed ID: 23032197
[TBL] [Abstract][Full Text] [Related]
5. Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
Inciardi RM; Claggett B; Minamisawa M; Shin SH; Selvaraj S; Gonçalves A; Wang W; Kitzman D; Matsushita K; Prasad NG; Su J; Skali H; Shah AM; Chen LY; Solomon SD
J Am Coll Cardiol; 2022 Apr; 79(16):1549-1561. PubMed ID: 35450571
[TBL] [Abstract][Full Text] [Related]
6. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
[TBL] [Abstract][Full Text] [Related]
7. Relationship between body mass index, cardiovascular biomarkers and incident heart failure.
Suthahar N; Meems LMG; Groothof D; Bakker SJL; Gansevoort RT; van Veldhuisen DJ; de Boer RA
Eur J Heart Fail; 2021 Mar; 23(3):396-402. PubMed ID: 33443299
[TBL] [Abstract][Full Text] [Related]
8. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
[TBL] [Abstract][Full Text] [Related]
9. Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.
Pellicori P; Ferreira JP; Mariottoni B; Brunner-La Rocca HP; Ahmed FZ; Verdonschot J; Collier T; Cuthbert JJ; Petutschnigg J; Mujaj B; Girerd N; González A; Clark AL; Cosmi F; Staessen JA; Heymans S; Latini R; Rossignol P; Zannad F; Cleland JGF
Eur J Heart Fail; 2020 Sep; 22(9):1711-1723. PubMed ID: 31950604
[TBL] [Abstract][Full Text] [Related]
10. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
11. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.
Kalogeropoulos AP; Georgiopoulou VV; deFilippi CR; Gottdiener JS; Butler J;
JACC Cardiovasc Imaging; 2012 Feb; 5(2):131-40. PubMed ID: 22340818
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits.
Nayor M; Short MI; Rasheed H; Lin H; Jonasson C; Yang Q; Hveem K; Felix JF; Morrison AC; Wild PS; Morley MP; Cappola TP; Benson MD; ; ; Ngo D; Sinha S; Keyes MJ; Shen D; Wang TJ; Larson MG; Brumpton BM; Gerszten RE; Omland T; Vasan RS
Circ Heart Fail; 2020 May; 13(5):e006749. PubMed ID: 32408813
[TBL] [Abstract][Full Text] [Related]
13. Circulating protein biomarkers predict incident hypertensive heart failure independently of N-terminal pro-B-type natriuretic peptide levels.
Fernandez C; Rysä J; Ström K; Nilsson J; Engström G; Orho-Melander M; Ruskoaho H; Melander O
ESC Heart Fail; 2020 Aug; 7(4):1891-1899. PubMed ID: 32410391
[TBL] [Abstract][Full Text] [Related]
14. Biomarker-based risk prediction in the community.
AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.
Wannamethee SG; Welsh P; Whincup PH; Lennon L; Papacosta O; Sattar N
Eur J Heart Fail; 2014 Jan; 16(1):25-32. PubMed ID: 23901058
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
[No Abstract] [Full Text] [Related]
17. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
Meijers WC; de Boer RA; van Veldhuisen DJ; Jaarsma T; Hillege HL; Maisel AS; Di Somma S; Voors AA; Peacock WF
Eur J Heart Fail; 2015 Dec; 17(12):1271-82. PubMed ID: 26466857
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Association and Risk Prediction With Heart Failure in Older Adults.
Liu G; Nguyen NQH; Wong KE; Agarwal SK; Boerwinkle E; Chang PP; Claggett BL; Loehr LR; Ma J; Matsushita K; Rodriguez CJ; Rossi JS; Russell SD; Stacey RB; Shah AM; Yu B
Circ Heart Fail; 2024 Mar; 17(3):e010896. PubMed ID: 38426319
[TBL] [Abstract][Full Text] [Related]
20. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
